Physicians' Academy for Cardiovascular Education

tes diab

Sep. 29, 2015

  10 minute education • 27-9-2015 • Dr David Fitchett

SGLT2 inhibitor outcome trials: Future opportunities

Dr Fitchett discusses the unmet glycemic control needs, the ongoing clinical trials with SGLT2 inhibitors and the EMPA-REG OUTCOME trial

Share this page with your colleagues and friends: